Open Access

A novel coumarin, (+)-3′-angeloxyloxy-4′-keto-3′,4′-dihydroseselin, isolated from Bupleurum malconense (Chaihu) inhibited NF-κB activity

Chinese Medicine201611:5

https://doi.org/10.1186/s13020-016-0077-x

Received: 5 August 2014

Accepted: 4 February 2016

Published: 13 February 2016

Abstract

Background

This study aims to identify the major anti-inflammatory components in the petroleum ether extract of Bupleurum malconense (Chaihu), by bioassay-guided fractionation, and to investigate the anti-inflammatory mechanisms of active components in lipopolysaccharide (LPS)-stimulated murine macrophage RAW-Blue cells.

Methods

A QUANTI-Blue assay was used to guide fractionation of B. malconense root extract. The petroleum ether extract which exerted significant secreted embryonic alkaline phosphatase (SEAP) inhibition effect was purified by silica gel column chromatography and assisted with reverse phase HPLC. The major bioactive compound which significantly inhibited SEAP activity was obtained and its anti-inflammatory effects in LPS-induced RAW-Blue cells were measured by the overproduction of NO (Griess method), gene expression of Il-, Tnf-α and iNos (real-time PCR). In parallel, protein expressions of COX-2, iNOS and IκB-α were determined by western blot.

Results

In bioassay-guided fractionation using LPS-stimulated mouse macrophage RAW-Blue cells, (+)-3′-angeloxyloxy-4′-keto-3′,4′-dihydroseselin (Pd-Ib) was identified by MS and NMR spectral analyses. Pd-Ib (5, 10, 20 μg/mL) suppressed the gene expression of Il- (P < 0.0001, P < 0.0001, P < 0.0001 for three respective concentrations), Tnf-α (P = 0.006, P = 0.001, P < 0.0001 for three respective concentrations) and iNos (P = 0.009, P < 0.0001, P < 0.0001 for three respective concentrations) in LPS-stimulated macrophages. The production of cyclooxygenase-2 (P = 0.019, P = 0.002, P < 0.0001), iNOS (P < 0.0001, P < 0.0001, P < 0.0001 for three respective concentrations) and NO (P < 0.0001, P < 0.0001, P < 0.0001 for three respective concentrations) significantly decreased when macrophages were treated with Pd-Ib (5, 10, 20 μg/mL) in the presence of LPS. Pd-Ib (5, 10, 20 μg/mL) suppressed the nuclear activation of NF-κB while it up-regulated the IκB-α level (P = 0.028, P = 0.013, P = 0.005 for three respective concentrations) in LPS-stimulated macrophages.

Conclusions

Pd-Ib isolated from B. malconense suppressed LPS-induced inflammatory responses in macrophages by inhibiting NF-κB activity and reducing the expression of iNOS, COX-2 as well as pro-inflammatory cytokines.

Background

Bupleurum is used for treatment of inflammation-related diseases, such as autoimmune diseases, inflammatory bowel syndrome and cholecystitis [13]. Nearly 50 Bupleurum species have been extensively studied for their phytochemical characteristics [4]. In general, the components of Bupleurum include essential oil and saponins [5, 6]. Saikosaponins are commonly recognized as the main components responsible for the anti-inflammatory activity of the Bupleurum species [79]. However, Bupleurum malconense, a species endemic to China, appears to little be known its major bioactive components [1012]. In a preliminary study of our group, the anti-inflammatory effect of B. malconense was evaluated in dextran sulfate sodium (DSS)-induced colitis mouse model. The petroleum ether extract of B. malconense exerted strong ameliorative effect on colon shortening and loss of the body weight (Additional file 1). As saikosaponins are polar, we believed that some compounds less polar than saikosaponins may be responsible for the anti-inflammatory properties of the petroleum ether (PE) extract of B. malconense.

This study aims to identify the anti-inflammatory components in the PE extract of B. malconense by QUANTI-Blue bioassay-guided fractionation, and to investigate the anti-inflammatory actions of these active components in LPS-stimulated murine macrophage RAW-Blue cells.

Methods

Chemicals

Lipopolysaccharides (LPS, L3129), 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide (MTT), dimethyl sulfoxide (DMSO), Griess reagent, and all chemicals used were of HPLC grade from Sigma Chemical Co. (St. Louis, MO, USA). Primers for inducible nitric oxide synthase gene (iNos), interleukin 1 beta gene (Il-) and tumor necrosis factor alpha gene (Tnf-α), beta-actin gene (β-Actin) (Table 1), Trizol reagent, SYBR Green, Dulbecco’s modified Eagle’s medium (DMEM), ECL reagent, fetal bovine serum (FBS), penicillin and streptomycin were purchased from Life Technologies (Carlsbad, CA, USA). BCA protein assay kit was purchased by Thermo Fisher Scientific (Waltham, MA, USA). Nuclear factor-kappa B (NF-κB), I-kappa B alpha (IκB-α), cyclooxygenase-2 (COX-2) and iNOS rabbit antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). β-actin mouse antibody, anti-rabbit IgG and anti-mouse IgG were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). QUANTI-Blue medium and Alexa Fluor568@ anti-rabbit IgG were purchased from InvivoGen (San Diego, CA, USA). Fractions were monitored and combined by thin layer chromatography. Spots were made visible by heating silica gel plates that had been immersed in 5 % H2SO4 in ethanol (EtOH).
Table 1

Sequence of primers used in real-time PCR

Gene

Primer

Sequence (5′–3′)

iNos

Sense

CACCTTGGAGTTCACCCAGT

Antisense

ACCACTCGTACTTGGGATGC

Tnf-α

Sense

CTGTGAAGGGAATGGGTGTT

Antisense

GGTCACTGTCCCAGCATCTT

Il-

Sense

GCTGAAGGAGTTGCCAGAAA

Antisense

GTGCAAGTGACTCAGGGTGA

β-Actin

Sense

GGTGAAGGTCGGTGGAACG

Antisense

CTCGCTCCTGGAAGATGGTG

Plant material

The dried roots of B. malconense were collected from Sichuan Province, China. The plant material was identified and authenticated by Dr. Linfang Huang based on sequences of the plastid psbA-trnH intergenic region [13, 14]. The sequences of plant material (ZSH1 and ZSH2) highly matched the sequence of B. malconense (GenBank accession: JN788921) (Additional file 2).

Extraction and isolation

Air-dried pieces of B. malconense root (500 g) were extracted three times by percolation in PE (1 L). The supernatant, which was concentrated and collected, was the PE extract. The residue was extracted three times by reflux in 80 % EtOH at 60 °C. The solution was concentrated to yield an 80 % EtOH. Then, the residue was further extracted by reflux in water (1 L) for three times to obtain the aqueous extract. Meanwhile, the 80 % EtOH extract was dissolved in 200 mL of water in a separatory funnel, and then partitioned with ethyl acetate (EtOAc, 200 mL × 3). The upper and lower layers were collected to yield the EtOAc extract and EtOH extract, respectively. After freeze-drying (Labconoco, Kansas, MO, USA), extracts were weighted, and the related percent composition was calculated, with the following results: PE extract (0.8 g, 0.2 %), EtOAc extract (4.7 g, 0.9 %), EtOH extract (25.3 g, 5.1 %), aqueous extract (24.2 g, 4.8 %). All extracts were stored at −20 °C.

The PE extract was subjected to silica gel column chromatography (300–400 mesh, Davisil, Germany) using PE/EtOAc with increasing polarity as eluent. Pd-Ib, which was obtained from fraction 3 (Fr. 3) with 2.5 % EtOAc in PE, was further purified by reverse phase HPLC (Waters system including a 2545 binary gradient module, a 2489 UV/Visible detector and a fraction collector III) on the semi-preparative column Preparative RP-C18 (Alltech Alltima-C18, 250 mm × 10 mm, 5 μm). The separation flow chart (together with bioassay) is shown in Fig. 1.
Fig. 1

Flow chart of bioassay-guided isolation of the anti-inflammatory compound of B. malconense. The effect of test samples on SEAP activity in LPS-stimulated RAW-Blue cells. *P < 0.05, **P < 0.01 and ***P < 0.001 vs. LPS-alone group. PE ext petroleum ether extract, EtOAc ethyl acetate extract, EtOH ethanol extract, H 2 O water extract, Fr fraction, con vehicle control group

Anti-inflammatory bioassay

RAW-Blue cells (5 × 104/well) were cultured in 96-well plates for 24 h, and then treated with LPS (1 μg/mL) alone or together with test samples for 20 h. Secreted embryonic alkaline phosphatase (SEAP) activity in the medium was determined by QUANTI-Blue medium following the manufacturer’s instructions. Briefly, 100 μL of samples were added to 200 μL of QUANTI-Blue medium and incubated at 37 °C for 15–30 min. Absorbance was measured at 620 nm by a microplate reader (Benchmark plus Bio-Red, Hercules, CA, USA), and fold change in SEAP activity was calculated.

Cell culture

RAW-Blue cells were derived from RAW264.7 murine macrophages. RAW-Blue cells were cultured in plastic dishes containing DMEM supplemented with 100 U/mL penicillin, 100 μg/mL streptomycin and 10 % FBS in an incubator (5 % CO2) at 37 °C. Cells were sub-cultured every 3 days at a dilution of 1:6.

Cell viability assay

Cells (5 × 104/well) were cultured in 96-well plates for 24 h, and then cultured with various concentrations of Pd-Ib (1.25, 2.5, 5, 10, 20, 40, 80, and 100 μg/mL) for 24 h. Then, 10 μL of 5 mg/mL MTT were added to each well, and the cells were cultured in the dark for 3 h. The medium was then discarded, and 100-μL portions of DMSO were added into each well. After 15 min incubation, the optical density at 570 nm was measured by a microplate reader to determine the cell viability.

Western blot analysis

After RAW-Blue cells were treated with LPS (1 μg/mL) and various concentrations of Pd-Ib (5, 10, 20 μg/mL) for 24 h, total proteins were extracted by lysis buffer [150 mM NaCl, 1 mM EDTA, 1 % NP-40, 2 mM EGTA, 50 mM Tris (pH 7.4)] with phosphatase and protease inhibitors (Roche, Mannheim, Germany). Cell extracts were centrifuged by centrifugation (5424R, Eppendorf, Hamburg, Germany) at 17,000×g for 15 min at 4 °C. The amount of total protein concentration was quantified by the BCA protein assay kit (Thermo Fisher Scientific, Waltham, MA, USA). Then, 10–25 μg proteins were loaded and separated on sodium dodecylsulphate-polyacrylamide gel (10 % SDS-PAGE), which were further transferred onto polyvinylidene difluoride membranes. The membranes were incubated with various primary antibodies, namely, anti-COX-2, anti-iNOS, anti-IκB-α, and anti-β-actin (1:5000) in 5 % skim milk (wt/vol) in TBST overnight at 4 °C, after blocking with 5 % skim milk (wt/vol) in Tris-buffered saline-Tween [TBST; 150 mM NaCl, 50 mM Tris, 0.05 % Tween-20 (pH 7.4)] for 1 h. After washing with TBST for three times (10 min for each time), the membranes were blocked with secondary antibodies (1:2000) in 5 % skim milk (wt/vol) in TBST for 1 h, following with TBST washed (3 × 10 min). The amount of immunoreactive proteins was detected by enhanced chemiluminescence ECL reagent and X-ray film. The protein bands were quantified using the ImageJ Software (version 4.1.7, NIH, Bethesda, MD, USA) by their relative intensity compared with the control.

Immunofluorescence staining

RAW-Blue cells were cultured (2 × 105 cells/well) on glass coverslips and incubated for 24 h. Cells were pretreated with Pd-Ib (20 μg/mL) for 2 h and then with LPS (1 μg/mL) for 20 h. Subsequently, the coverslips were rinsed twice with phosphate buffer saline, and cells were fixed in 4 % paraformaldehyde in PBS at room temperature for 15 min. Cellular and nuclear membranes of the macrophages were permeabilized by treatment with 3 % Triton X-100 in PBS for 15 min. After being blocked with 3 % bovine serum albumin (BSA) in PBS for 1 h, the cells was incubated with primary antibodies in 3 % BSA/PBS (1:500 dilution) at 4 °C overnight. After washing with PBS, the cells were incubated with the Alexa Fluor568-conjugated secondary antibodies (1:500 dilution) in 3 % BSA/PBS at room temperature for 1 h, and finally washed again three time with PBS. Then, counter-staining of nuclei was performed with 4′,6-diamidino-2-phenylindole (DAPI; 1:1000 dilution) in 3 % BSA/PBS for 10 min. The cells were washed three times with PBS, and then anti-fade mounting medium was added. Samples were observed under a fluorescence microscope (DMI3000B, Leisa Microsystems, Wetzlar, Germany).

Real-time quantitative polymerase chain reaction (qPCR) analysis

2 × 106 cells/well RAW-Blue cells were seeded in 12-well plates. After 24 h, cells were pretreated with Pd-Ib at different concentrations (5–20 μg/mL) or untreated (control) for 2 h, following co-cultured with LPS (1 μg/mL) for 20 h. TRIzol reagent was used to extract the total RNA. Then, 2 μg of total RNA was reverse-transcribed to cDNA with RT master mix. Real-time qPCR was performed with the SYBR Green kit in a ViiA7 real-time PCR instrument (Life Technologies, Waltham, Massachusetts, USA). The comparative cycle of threshold (ΔΔCT) method of relative quantification was used to analyze the target gene expression. The accuracy of the amplicon was verified using melting curve analysis. Primer sequences of Il-, Tnf-α, iNos and β-Actin for mRNA analysis are listed in Table 1.

Nitric oxide production determination

Nitric oxide (NO) production was indirectly assessed by measuring the nitrite levels in the cultured medium determined by a colorimetric method based on the Griess reagent and sodium nitrite as a standard substance. The cells were pretreated with various concentrations of Pd-Ib (5–20 μg/mL). Two hours later, cells were incubated for another 20 h in the presence of LPS (1 μg/mL) at 37 °C. Then, 100 μL of each supernatant were mixed with an equal volume of Griess reagent. The samples were incubated at room temperature for 15 min. The optical densities were measured at 540 nm by a microplate reader, and nitrite concentration was determined by a standard curve generated with known concentrations of sodium nitrite.

Statistical analysis

Experiments were performed at least three times as indicated. Data were presented as mean ± SD from three independent experiments. Statistical differences among groups were evaluated by one-way analysis of variance (ANOVA) and Duncan’s multiple range test by IBM SPSS Statistics 20 for Windows (SPSS Inc., Chicago, IL, USA). P values <0.05 were considered statistically significant. The dose-dependence was visually determined.

Results and discussion

Bioassay-guided isolation and structural identification

As shown in Fig. 1, upon LPS stimulation, The SEAP activity was significantly inhibited by the addition of the PE extract (50 μg/mL) (16.52–9.86 %, P < 0.0001). The PE extract was subjected to silica gel chromatography using PE/EtOAc as an eluent and eight fractions were collected to further search for anti-inflammatory compounds. Because the SEAP activity was significantly inhibited by Fr. 3 (24.67–36.65 %, P < 0.0001), further purification was carried out to isolate one pure compound. This compound, which inhibited the SEAP activity (IC50 = 22.53 μg/mL) in the LPS-stimulated macrophages in a dose-dependent manner, was determined to be Pd-Ib by HR-MS analysis (MicrOToF-Q Bruker mass spectrometer equipped with Acquity Waters ultra-high performance liquid chromatography) and NMR spectra analysis (Bruker 400 Hz NMR spectrometer). The spectral data (Additional files 3 and 4) are identical to those reported [1517]. To our knowledge, this is the first time that Pd-Ib has been found in B. malconense.

Pd-Ib yield: 2.38 mg of white powder (MeOH). HR-ESI+-MS: m/z 342.1183 [M+H]+ (calculated for C19H18O6, 342.1182). 1H-NMR (CDCl3, 400 MHz) δ: 6.35 (1H, d, J = 9. 6 Hz, H-3), 7.63 (1H, d, J = 9.6 Hz, H-4), 7.57 (1H, d, J = 8.4 Hz, H-5), 6.90 (1H, d, J = 8.8 Hz, H-6), 5.69 (1H, s, J = 4.8 Hz, H-3′), 1.62 (3H, s, 5′-CH3), 1.45 (3H, s, 5′-CH3), 6.25 (1H, q, J = 7. 5 Hz, H-3″), 2.07 (3H, d, J = 8.8 Hz, 4″-CH3), 2.00 (3H, s, 5″-CH3).

Cytotoxicity of Pd-Ib in RAW-Blue cells

The cytotoxic effect of Pd-Ib on RAW-Blue cells was tested with the MTT assay. As shown in Fig. 2, Pd-Ib did not exhibit cytotoxic effects at dosages ranging from 1.56 to 20 μg/mL; however, the cell viability decreased when the macrophages were treated with Pd-Ib at doses of 40, 80 or 100 μg/mL.
Fig. 2

Effect of Pd-Ib on the viability of LPS-stimulated RAW-Blue cells. Cells were cultured for 24 h in the presence of Pd-Ib at the indicated concentrations (1.25–100 μg/mL). Cell viability was assessed by the MTT assay. Data were obtained from three independent experiments and presented as mean ± SD. con vehicle control group

Pd-Ib inhibited the nuclear translocation of NF-κB and decreased degradation of IκB-α in LPS-stimulated RAW-Blue cells

The SEAP activity in the supernatants of the LPS-stimulated RAW-Blue cells reflects the activation of NF-κB [18]. NF-κB activation is involved in a number of cellular processes, particularly inflammation. The inhibition of NF-κB activation was associated with the mitigation of colon inflammation responses and apoptosis of intestinal epithelial cells in the DSS mouse model [19]. In our in vitro study, the immunofluorescence analysis showed that the nuclear translocation of NF-κB p65 subunit in the LPS-stimulated cells was remarkably up-regulated when comparing to that of the non-LPS-treated control, denoting the activation of NF-κB. When Pd-Ib (20 μg/mL) treatment was given, the translocation of NF-κB p65 was inhibited (Fig. 3).
Fig. 3

Effect of Pd-Ib on inhibited the IκB-α degradation in LPS-stimulated RAW-Blue cells. After macrophages were treated with 1 μg/mL of LPS in absence or presence of various concentrations of Pd-Ib (5, 10 and 20 μg/mL) for 20 h, the protein level of IκB-α was determined by western blotting, β-actin was used as a loading control. a Representative image of western blotting. b The protein level of IκB-α was calculated with ImageJ software. Data were derived from three independent experiments and presented as mean ± SD. # Compared with the control group. *P < 0.05 and **P < 0.01 vs. LPS-alone group

In contrast, the expression of the inhibitory subunit of NF-κB, IκB-α was clearly depredated in macrophages upon LPS stimulation. From the western blotting images, we demonstrated that the loss of cytoplasmic IκB-α was inhibited by Pd-Ib (5, 10, 20 μg/mL) in a dose-dependent manner when compared with the LPS-stimulated macrophages (P = 0.028, P = 0.013, P = 0.005 for three respective concentrations; Fig. 4).
Fig. 4

Effect of Pd-Ib on the nuclear translocation of NF-κB. Macrophages were pre-incubated with Pd-Ib (20 μg/mL) for 2 h and then with or without 1 μg/mL of LPS for 20 h. And then Nuclei were stained with DAPI for immunofluorescence staining analysis. Data were derived from three independent experiments. Original magnification, ×40

Pd-Ib suppressed the expression of iNOS and COX-2 in LPS-stimulated RAW-Blue cells

COX-2 and iNOS are known to mediate inflammatory responses. High expression levels cause intestinal inflammation with motility dysfunction [20]. Pd-Ib (5, 10, 20 μg/mL) strongly down-regulated iNOS (P < 0.0001, P < 0.0001, P < 0.0001 for three respective concentrations) and COX-2 (P = 0.019, P = 0.002, P < 0.0001 for three respective concentrations) protein levels in a dose-dependent manner (Fig. 5a, b).
Fig. 5

Inhibitory effect of Pd-Ib on iNOS and COX-2 expression in LPS-stimulated RAW-Blue cells. After macrophages were treated with 1 μg/mL LPS in the absence or presence of various concentrations of Pd-Ib (5, 10 and 20 μg/mL) for 20 h, the protein levels of iNOS and COX-2 were determined by western blotting; β-actin was used as a loading control. a Representative western blotting images. b The protein levels of iNOS and COX-2 were calculated with ImageJ software. Data were derived from three independent experiments and presented as mean ± SD. #Compared with the control group. *P < 0.05, **P < 0.01 and ***P < 0.001 vs. LPS-alone group

Furthermore, the effect of Pd-Ib on the mRNA expression of iNos was investigated in LPS-stimulated RAW-Blue cells. As shown in Fig. 6a, Pd-Ib (5, 10, 20 μg/mL) also markedly inhibited the mRNA level of iNos (P < 0.0001, P < 0.0001, P < 0.0001 for three respective concentrations) in a dose-dependent manner. Pd-Ib plays a key role in the inhibition of iNOS protein and gene expression.
Fig. 6

Effect of pro-inflammatory factors expression on nitric oxide production in LPS-stimulated RAW-Blue cells. After macrophages were treated with 1 μg/mL LPS in the absence or presence of various concentrations of Pd-Ib (5, 10 and 20 μg/mL) for 20 h, the mRNA levels of iNos (a) Tnf-α (b) and Il- (c) were determined by real-time PCR, and the production of NO (d) was determined by Griess reagent. Data were derived from three independent experiments and presented as mean ± SD. con vehicle control group. #Compared with the control group. *P < 0.05, **P < 0.01 and ***P < 0.001 vs. LPS-alone group

Pd-Ib inhibited the mRNA expression of Tnf-α and Il- in LPS-stimulated RAW-Blue cells

High levels of pro-inflammatory cytokines are associated with pain, lung inflammation and rheumatoid arthritis [2123]. In this study, the mRNA expression of pro-inflammatory cytokines was examined by real-time qPCR. As shown in Fig. 6b, c, Pd-Ib (5, 10, 20 μg/mL) inhibited the mRNA expression of Tnf-α (P < 0.006, P < 0.001, P < 0.0001 for three respective concentrations) and Il- (P < 0.001, P < 0.0001, P < 0.0001 for three respective concentrations) in a dose-dependent manner, while LPS stimulation of macrophages caused an increase in their expression.

Pd-Ib inhibited NO production in LPS-stimulated RAW-Blue cells

Production of excessive amounts of NO leads to inflammatory responses or tissue injury [24]. As shown in Fig. 6d, LPS stimulation significantly increased NO production compared with the control group, while treatment with 5, 10 or 20 μg/mL Pd-Ib led to 17.64 ± 2.96, 29.82 ± 1.34 and 55.45 ± 1.15 % (P < 0.0001, P < 0.0001, P < 0.0001 for three respective concentrations) inhibition of NO production, respectively.

Pd-Ib exerted anti-inflammatory effects through inhibition of SEAP activity in the QUANTI-Blue assay. SEAP is a reporter gene widely used to screen immune-pharmacological activities upon the activation of NF-κB and activator protein 1 (AP-1) [25, 26]. When RAW-Blue cells are stimulated with LPS, IκB-α, which is the inhibitory subunit of NF-κB, is rapidly phosphorylated. Subsequently, NF-κB releases from the IκB-α subunit and translocates to the nucleus, where it increases the expression of the genes that encode many cytokines, enzymes and adhesion molecules [27]. Pd-Ib significantly inhibited the LPS-stimulated degradation of IκB-α and the nuclear translocation of NF-κB.

Increased expression of two key factors regulated by NF-κB, COX-2 and iNOS, is reflected in the increased amount of NO in the colon of patients with active ulcerative colitis [28]. Pd-Ib significantly inhibited the protein expression of COX-2 and iNOS, resulting in a decrease in NO in activated macrophages. The results also suggest that Pd-Ib down-regulated the protein levels of iNOS by reducing its mRNA expression.

When the pro-inflammatory cytokines, including TNF-α and IL-1β, are overproduced, often lead to inflammatory process [29]. Thus, inhibition of the release of pro-inflammatory cytokines may attenuate the inflammatory response [30]. Our qPCR results showed that Pd-Ib significantly down-regulated the mRNA expression of Tnf-α and Il- in a dose-dependent manner. Our finding of Pd-Ib agreed to the previous studies [3133] that many natural compounds inhibiting TNF-α activation suppress the nuclear expression of NF-κB.

Conclusion

Pd-Ib isolated from B. malconense suppressed LPS-induced inflammatory responses in macrophages by inhibiting NF-κB activity and reducing the expression of iNOS, COX-2 as well as pro-inflammatory cytokines.

Abbreviations

LPS: 

lipopolysaccharide

Pd-Ib: 

(+)-3′-angeloxyloxy-4′-keto-3′,4′-dihydroseselin

qPCR: 

quantitative polymerase chain reaction

IL-1β: 

interleukin 1 beta

TNF-α: 

tumor necrosis factor-alpha

iNOS: 

inducible nitric oxide synthase

COX-2: 

cyclooxygenase-2

NO: 

nitric oxide

NF-κB: 

nuclear factor kappa-light-chain-enhancer of activated B cells

IκB-α: 

nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha

DSS: 

dextran sulfate sodium

MTT: 

3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide

DMSO: 

dimethyl sulfoxide

DMEM: 

Dulbecco’s modified Eagle’s medium

FBS: 

fetal bovine serum

PE: 

petroleum ether

EtOAc: 

ethyl acetate

Fr: 

fraction

EtOH: 

ethanol extract

H2O: 

water extract

con: 

vehicle control group

SEAP: 

secreted embryonic alkaline phosphatase

SDS-PAGE: 

sodium dodecylsulphate-polyacrylamide gel

TBST: 

tris-buffered saline-Tween

BSA: 

bovine serum albumin

PBS: 

phosphate buffer saline

DAPI: 

4′,6-diamidino-2-phenylindole

AP-1: 

activator protein 1

Declarations

Authors’ contributions

ZXB, QBH, DJY and APL conceived and designed the study. HXM, CYL, LFH performed the experiment and collected the data. HXM wrote the manuscript. ZXB and QBH revised the work. All authors read and approved the final manuscript.

Acknowledgements

This work was supported by Hong Kong Baptist University research Grant No. IRMS-HKBU2011.

Competing interests

The authors declare that they have no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
School of Chinese Medicine, Hong Kong Baptist University
(2)
Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences
(3)
Chongqing Academy of Chinese Materia Medica

References

  1. Jiang YW, Li H, Zhang YY, Li W, Jiang YF, Ou YY, Chen DF. Beneficial effect of Bupleurum polysaccharides on autoimmune-prone MRL-lpr mice. Clin Dev Immunol. 2012. doi:https://doi.org/10.1155/2012/842928.PubMed CentralPubMedGoogle Scholar
  2. Shih YC, Lee LT, Hu NY, Tong TS. Pharmaceutical composition for treating or releiving inflammatory bowel disease. 2012; Pat. No.: EP 2402021.Google Scholar
  3. Moga MM. Alternative treatment of gallbladder disease. Med Hypotheses. 2003;60:143–7.View ArticlePubMedGoogle Scholar
  4. Ashour ML, Wink M. Genus Bupleurum: a review of its phytochemistry, pharmacology and modes of action. J Pharm Pharmacol. 2011;63:305–21.View ArticlePubMedGoogle Scholar
  5. Saracoglu HT, Zengin G, Akin M, Aktumsek A. Evaluation of oil content and fatty acid composition of five endemic Bupleurum species growing in the Central Anatolia region of Turkey. Nat Prod Res. 2012;26:1188–94.View ArticlePubMedGoogle Scholar
  6. Lee J, Yang DH, Suh JH, Kim U, Eom HY, Kim J, Lee MY, Lee MY, Kim J, Han SB. Species discrimination of Radix Bupleuri through the simultaneous determination of ten saikosaponins by high performance liquid chromatography with evaporative light scattering detection and electrospray ionization mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879:3887–95.View ArticlePubMedGoogle Scholar
  7. Chen MF, Huang CC, Liu PS, Chen CH, Shiu LY. Saikosaponin a and saikosaponin d inhibit proliferation and migratory activity of rat HSC-T6 cells. J Med Food. 2013;16:793–800.PubMed CentralView ArticlePubMedGoogle Scholar
  8. Lu CN, Yuan ZG, Zhang XL, Yan R, Zhao YQ, Liao M, Chen JX. Saikosaponin a and its epimer saikosaponin d exhibit anti-inflammatory activity by suppressing activation of NF-kappaB signaling pathway. Int Immunopharmacol. 2012;14:121–6.View ArticlePubMedGoogle Scholar
  9. Leung CY, Liu L, Wong RN, Zeng YY, Li M, Zhou H. Saikosaponin-d inhibits T cell activation through the modulation of PKCtheta, JNK, and NF-kappaB transcription factor. Biochem Biophys Res Commun. 2005;338:1920–7.View ArticlePubMedGoogle Scholar
  10. Li XQ, Gao QT, Chen XH, Bi KS. High performance liquid chromatographic assay of saikosaponins from Radix Bupleuri in China. Biol Pharm Bull. 2005;28:1736–42.View ArticlePubMedGoogle Scholar
  11. Li XQ, He ZG, Bi KS, Song ZH, Xu L. Essential oil analyses of the root oils of 10 Bupleurum species from China. J Essent Oil Res. 2007;19:234–8.View ArticleGoogle Scholar
  12. Li XQ, Sun XY, Chen XH, Wang X, Bi KS. GC fingerprint analysis for quality control of volatile oil in Radix Bupleuri. Zhongyaocai. 2006;37:1165–7.Google Scholar
  13. Zheng SH, Liu DW, Ren WG, Fu J, Huang LF, Chen SL. Integrated analysis for identifying Radix Astragali and its adulterants based on DNA barcoding. Evid-based Complement Altern Med. 2014. doi:https://doi.org/10.1155/2014/843923.Google Scholar
  14. Zheng SH, Jiang X, Wu LB, Wang ZH, Huang LF. Chemical and genetic discrimination of Cistanches Herba based on UPLC-QTOF/MS and DNA barcoding. PLoS ONE. 2014;9(5):e98061.PubMed CentralView ArticlePubMedGoogle Scholar
  15. Zhang C, Xiao YQ, Li L, Taniguchi M, Baba K. Chemical constituents from roots of Peucedanum praeruptorum (V). Zhongguo Zhong Yao Za Zhi. 2012;37:3573–6.PubMedGoogle Scholar
  16. Wang XB, Shi YR, Kong LY. +)-(3′R)-angeloxyloxy-4′-oxo-3′,4′-dihydroseselin (Pd–Ib. Acta Crystallogr E. 2006;E62:o2505–7.View ArticleGoogle Scholar
  17. Liu R, Feng L, Sun A, Kong L. Preparative isolation and purification of coumarins from Peucedanum praeruptorum Dunn by high-speed counter-current chromatography. J Chromatogr A. 2004;1057:89–94.View ArticlePubMedGoogle Scholar
  18. Constantinescu AA, Gleizes C, Alhosin M, Yala E, Zobairi F, Leclercq A, Stoian G, Mitrea IL, Prevost G, Toti F, Kessler L. Exocrine cell-derived microparticles in response to lipopolysaccharide promote endocrine dysfunction in cystic fibrosis. J Cyst Fibros. 2014;13:219–26.View ArticlePubMedGoogle Scholar
  19. Xiao HT, Lin CY, Ho DH, Peng J, Chen Y, Tsang SW, Wong M, Zhang XJ, Zhang M, Bian ZX. Inhibitory effect of the gallotannin corilagin on dextran sulfate sodium-induced murine ulcerative colitis. J Nat Prod. 2013;76:2120–5.View ArticlePubMedGoogle Scholar
  20. Tajima T, Murata T, Aritake K, Urade Y, Michishita M, Matsuoka T, Narumiya S, Ozaki H, Hori M. EP2 and EP4 receptors on muscularis resident macrophages mediate LPS-induced intestinal dysmotility via iNOS upregulation through cAMP/ERK signals. Am J Physiol-Gastroint Liver Physiol. 2012;302:G524–34.View ArticleGoogle Scholar
  21. DeVon HA, Piano MR, Rosenfeld AG, Hoppensteadt DA. The association of pain with protein inflammatory biomarkers: a review of the literature. Nurs Res. 2014;63:51–62.View ArticlePubMedGoogle Scholar
  22. Lim HJ, Woo KW, Lee KR, Lee SK, Kim HP. Inhibition of proinflammatory cytokine generation in lung inflammation by the leaves of Perilla frutescens and its constituents. Biomol Ther. 2014;22:62–7.View ArticleGoogle Scholar
  23. Yang DJ, Chang YY, Lin HW, Chen YC, Hsu SH, Lin JT. Inhibitory effect of litchi (Litchi chinensis Sonn.) flower on lipopolysaccharide-induced expression of proinflammatory mediators in RAW264.7 cells through NF-κB, ERK, and JAK2/STAT3 inactivation. J Agric Food Chem. 2014;62:3458–65.View ArticlePubMedGoogle Scholar
  24. Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sci. 2004;75:639–53.View ArticlePubMedGoogle Scholar
  25. Zhou HF, Xie CH, Jian RJ, Kang J, Li Y, Zhuang CL, Yang F, Zhang LL, Lai L, Wu T, Wu XL. Biflavonoids from Caper (Capparis spinosa L.) fruits and their effects in inhibiting NF-kappa B activation. J Agric Food Chem. 2011;59:3060–5.View ArticlePubMedGoogle Scholar
  26. Lewis RE, Liao G, Young K, Douglas C, Kontoyiannis DP. Macrophage reporter cell assay for screening immunopharmacological activity of cell wall-active antifungals. Antimicrob Agents Ch. 2014;58:1738–43.View ArticleGoogle Scholar
  27. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066–71.View ArticlePubMedGoogle Scholar
  28. Lundberg JO, Hellstrom PM, Lundberg JM, Alving K. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet. 1994;344:1673–4.View ArticlePubMedGoogle Scholar
  29. Muzes G, Molnar B, Tulassay Z, Sipos F. Changes of the cytokine profile in inflammatory bowel diseases. World J Gastroentero. 2012;18:5848–61.View ArticleGoogle Scholar
  30. Candiracci M, Candiracci M, Piatti E, Dominguez-Barragan M, Garcia-Antras D, Morgado B, Ruano D, Gutierrez JF, Parrado J, Castano A. Anti-inflammatory activity of a honey flavonoid extract on lipopolysaccharide-activated N13 microglial cells. J Agric Food Chem. 2012;60:12304–11.View ArticlePubMedGoogle Scholar
  31. Chan DSH, Lee HM, Yang F, Che CM, Wong CCL, Abagyan R, Leung CH, Ma DL. Structure-based discovery of natural-product-like TNF-α inhibitors. Angew Chem Int Ed Engl. 2010;49:2860–4.PubMed CentralView ArticlePubMedGoogle Scholar
  32. Leung CH, Chan DSH, Kwan MHT, Cheng Z, Wong CY, Zhu GY, Fong WF, Ma DL. Structure-based repurposing of FDA-approved drugs as TNF-α inhibitors. Chem Med Chem. 2011;6:765–8.View ArticlePubMedGoogle Scholar
  33. Li J, Zhang HB, Huang WL, Qian H, Li Y. TNF-α inhibitors with anti-oxidative stress activity from natural products. Curr Top Med Chem. 2012;12:1408–21.View ArticlePubMedGoogle Scholar

Copyright

© Mu et al. 2016

Advertisement